Recent Finacing
Recent Raise
Romark Laboratories develops thiazolide-derived therapies and markets an approved antidiarrheal drug while conducting clinical trials of the compound for hepatitis, gastroenteritis, and Crohn’s disease, based in Tampa.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor